BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17038881)

  • 1. Pharmacokinetics of intravenous rifampicin (rifampin) in neonates.
    Pullen J; Stolk LM; Degraeuwe PL; van Tiel FH; Neef C; Zimmermann LJ
    Ther Drug Monit; 2006 Oct; 28(5):654-61. PubMed ID: 17038881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics and dosing of flucloxacillin in preterm and term neonates.
    Pullen J; de Rozario L; Stolk LM; Degraeuwe PL; van Tiel FH; Zimmermann LJ
    Ther Drug Monit; 2006 Jun; 28(3):351-8. PubMed ID: 16778719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics and dosing of amoxicillin in (pre)term neonates.
    Pullen J; Stolk LM; Nieman FH; Degraeuwe PL; van Tiel FH; Zimmermann LJ
    Ther Drug Monit; 2006 Apr; 28(2):226-31. PubMed ID: 16628135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
    Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
    Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetic parameters of vancomycin in critically ill patients.
    Llopis-Salvia P; Jiménez-Torres NV
    J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative analysis of rifampicin and 25-desacetylrifampicin in the plasma using high performance liquid chromatography].
    Manuĭlov KK; Gagaeva EV
    Antibiot Khimioter; 1989 Sep; 34(9):682-4. PubMed ID: 2610536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amoxicillin pharmacokinetics in (preterm) infants aged 10 to 52 days: effect of postnatal age.
    Pullen J; Driessen M; Stolk LM; Degraeuwe PL; van Tiel FH; Neef C; Zimmermann LJ
    Ther Drug Monit; 2007 Jun; 29(3):376-80. PubMed ID: 17529898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microanalysis of amoxicillin, flucloxacillin, and rifampicin in neonatal plasma.
    Pullen J; Stolk LM; Neef C; Zimmermann LJ
    Biomed Chromatogr; 2007 Dec; 21(12):1259-65. PubMed ID: 17604357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart Surgery.
    Su F; Gastonguay MR; Nicolson SC; DiLiberto M; Ocampo-Pelland A; Zuppa AF
    Anesth Analg; 2016 May; 122(5):1556-66. PubMed ID: 26218862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance.
    Anderson BJ; Allegaert K; Van den Anker JN; Cossey V; Holford NH
    Br J Clin Pharmacol; 2007 Jan; 63(1):75-84. PubMed ID: 16869817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a simple HPLC-UV method for rifampicin determination in plasma: Application to the study of rifampicin arteriovenous concentration gradient.
    Goutal S; Auvity S; Legrand T; Hauquier F; Cisternino S; Chapy H; Saba W; Tournier N
    J Pharm Biomed Anal; 2016 May; 123():173-8. PubMed ID: 26907700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
    Adane ED; Herald M; Koura F
    Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin dosing in neutropenic patients.
    Haeseker MB; Croes S; Neef C; Bruggeman CA; Stolk LM; Verbon A
    PLoS One; 2014; 9(11):e112008. PubMed ID: 25390637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring.
    Zhao W; Lopez E; Biran V; Durrmeyer X; Fakhoury M; Jacqz-Aigrain E
    Arch Dis Child; 2013 Jun; 98(6):449-53. PubMed ID: 23254142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
    Waineo MF; Kuhn TC; Brown DL
    J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Vancomycin Prediction Methods Based on Estimated Creatinine Clearance or Trough Levels.
    Haeseker M; Croes S; Neef C; Bruggeman C; Stolk L; Verbon A
    Ther Drug Monit; 2016 Feb; 38(1):120-6. PubMed ID: 26418699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a concomitant single oral dose of rifampicin on the pharmacokinetics of pravastatin in a two-phase, randomized, single-blind, placebo-controlled, crossover study in healthy Chinese male subjects.
    Deng S; Chen XP; Cao D; Yin T; Dai ZY; Luo J; Tang L; Li YJ
    Clin Ther; 2009 Jun; 31(6):1256-63. PubMed ID: 19695392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian forecasting of serum vancomycin concentrations in neonates and infants.
    Rodvold KA; Gentry CA; Plank GS; Kraus DM; Nickel E; Gross JR
    Ther Drug Monit; 1995 Jun; 17(3):239-46. PubMed ID: 7624919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using vancomycin concentrations for dosing daptomycin in a morbidly obese patient with renal insufficiency.
    Pai MP; Mercier RC; Allen SE
    Ann Pharmacother; 2006 Mar; 40(3):553-8. PubMed ID: 16507618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.